| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $7K | -33.3% | — |
| SG&A Expense | $108K | -14.6% | -5.3% |
| Interest Expense | $12K | -2.2% | +81.3% |
| Net Income | -$127K | +14.9% | +5.7% |
| EPS (Diluted) | -$0.01 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $808K | +602.2% | +2222.6% |
| Total Assets | $976K | +239.4% | +439.5% |
| Current Liabilities | $622K | +28.1% | +1082.8% |
| Total Liabilities | $849K | +8.4% | +113.9% |
| Stockholders' Equity | $127K | +125.5% | +158.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$155K | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $810K | — | — |